Carsten Corvey

USPTO Granted Patents = 15 (Patent Applications = 10)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 12.4

ph-index = 6

Forward Citations = 91(Granted Patents)

Location History:

Kelkheim, DE (2015)
Frankfurt-am-Main, DE (2014 - 2024)

Company Filing History:

Pieris Pharmaceuticals Gmbh

patents

Years Active: 2014-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11932704 - Trispecific and/or trivalent binding proteins (2024-03-19),

2. 11192960 - Trispecific and/or trivalent binding proteins (2021-12-07),

3. 10947284 - Fusion molecules (2021-03-16),

4. 10882922 - Trispecific and/or trivalent binding proteins (2021-01-05),

5. 10329334 - Proteins specific for pyoverdine and pyochelin (2019-06-25),

6. 10316071 - Fusion molecules (2019-06-11),

7. 10118952 - Proteins specific for pyoverdine and pyochelin (2018-11-06),

8. 10072056 - Proteins specific for pyoverdine and pyochelin (2018-09-11),

9. 10065998 - Proteins specific for pyoverdine and pyochelin (2018-09-04),

10. 9884898 - Proteins specific for pyoverdine and pyochelin (2018-02-06),

11. 9441040 - Antagonist antibodies and their fab fragments against GPVI and uses thereof (2016-09-13),

12. 9234039 - Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the same (2016-01-12),

13. 9221917 - Dual variable region antibody-like binding proteins having cross-over binding region orientation (2015-12-29),

14. 9181349 - Dual variable region antibody-like binding proteins having cross-over binding region orientation (2015-11-10),

15. 8852593 - Antagonist antibodies and their fab fragments against GPVI and uses thereof (2014-10-07),

Title: The Innovative Contributions of Carsten Corvey

Introduction: Carsten Corvey, an accomplished inventor based in Frankfurt am Main, Germany, has made significant strides in the field of biotechnology. With a portfolio of 15 patents to his name, Corvey is recognized for his pioneering work on advanced binding proteins that have important applications in therapeutic contexts.

Latest Patents: Among his latest patents are innovative trispecific and/or trivalent binding proteins. These ground-breaking proteins consist of four polypeptide chains that create three antigen-binding sites specifically designed to target one or more proteins. In his designs, the first pair of polypeptides features dual variable domains with a cross-over orientation, while the second pair includes a single variable domain. The disclosure also outlines methods for manufacturing these binding proteins and their diverse applications, positioning Corvey's work at the forefront of medical and pharmaceutical advancements.

Career Highlights: Carsten Corvey has built an impressive career in the biotechnology sector, collaborating with notable companies such as Sanofi and Pieris Pharmaceuticals GmbH. His contributions to the field are supported by a solid educational foundation and a commitment to innovative research.

Collaborations: Throughout his career, Corvey has worked alongside distinguished colleagues, including Christian Lange and Jochen Kruip. These collaborations have led to significant advancements in the understanding and application of binding protein technology, emphasizing the importance of teamwork in scientific innovation.

Conclusion: Carsten Corvey stands out as a key figure in the world of biotechnology, with a focus on the development of trispecific and/or trivalent binding proteins. His 15 patents reflect a commitment to creating solutions that have the potential to revolutionize therapeutic practices. As he continues to innovate, the impact of his work will undoubtedly resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.